Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2013 1
2014 3
2015 3
2016 8
2017 4
2018 4
2019 5
2020 7
Text availability
Article attribute
Article type
Publication date

Search Results

34 results
Results by year
Filters applied: . Clear all
Page 1
Combining radiotherapy with immunotherapy: the past, the present and the future.
Van Limbergen EJ, De Ruysscher DK, Olivo Pimentel V, Marcus D, Berbee M, Hoeben A, Rekers N, Theys J, Yaromina A, Dubois LJ, Lambin P. Van Limbergen EJ, et al. Among authors: Dubois LJ. Br J Radiol. 2017 Aug;90(1076):20170157. doi: 10.1259/bjr.20170157. Epub 2017 May 25. Br J Radiol. 2017. PMID: 28541096 Free PMC article. Review.
Drug Resistance in Non-Small Cell Lung Cancer: A Potential for NOTCH Targeting?
Sosa Iglesias V, Giuranno L, Dubois LJ, Theys J, Vooijs M. Sosa Iglesias V, et al. Among authors: Dubois LJ. Front Oncol. 2018 Jul 24;8:267. doi: 10.3389/fonc.2018.00267. eCollection 2018. Front Oncol. 2018. PMID: 30087852 Free PMC article. Review.
HIF-1α and HIF-2α Differently Regulate the Radiation Sensitivity of NSCLC Cells.
Moreno Roig E, Groot AJ, Yaromina A, Hendrickx TC, Barbeau LMO, Giuranno L, Dams G, Ient J, Olivo Pimentel V, van Gisbergen MW, Dubois LJ, Vooijs MA. Moreno Roig E, et al. Among authors: Dubois LJ. Cells. 2019 Jan 12;8(1):45. doi: 10.3390/cells8010045. Cells. 2019. PMID: 30642030 Free PMC article.
The immunocytokine L19-IL2: An interplay between radiotherapy and long-lasting systemic anti-tumour immune responses.
Rekers NH, Olivo Pimentel V, Yaromina A, Lieuwes NG, Biemans R, Zegers CML, Germeraad WTV, Van Limbergen EJ, Neri D, Dubois LJ, Lambin P. Rekers NH, et al. Among authors: Dubois LJ. Oncoimmunology. 2018 Jan 16;7(4):e1414119. doi: 10.1080/2162402X.2017.1414119. eCollection 2018. Oncoimmunology. 2018. PMID: 29632732 Free PMC article.
Evofosfamide sensitizes esophageal carcinomas to radiation without increasing normal tissue toxicity.
Spiegelberg L, van Hoof SJ, Biemans R, Lieuwes NG, Marcus D, Niemans R, Theys J, Yaromina A, Lambin P, Verhaegen F, Dubois LJ. Spiegelberg L, et al. Among authors: Dubois LJ. Radiother Oncol. 2019 Dec;141:247-255. doi: 10.1016/j.radonc.2019.06.034. Epub 2019 Aug 17. Radiother Oncol. 2019. PMID: 31431383 Free PMC article.
Nitroglycerin as a radiosensitizer in non-small cell lung cancer: Results of a prospective imaging-based phase II trial.
Reymen BJT, van Gisbergen MW, Even AJG, Zegers CML, Das M, Vegt E, Wildberger JE, Mottaghy FM, Yaromina A, Dubois LJ, van Elmpt W, De Ruysscher D, Lambin P. Reymen BJT, et al. Among authors: Dubois LJ. Clin Transl Radiat Oncol. 2019 Dec 13;21:49-55. doi: 10.1016/j.ctro.2019.12.002. eCollection 2020 Mar. Clin Transl Radiat Oncol. 2019. PMID: 32021913 Free PMC article.
Advancing Clostridia to Clinical Trial: Past Lessons and Recent Progress.
Mowday AM, Guise CP, Ackerley DF, Minton NP, Lambin P, Dubois LJ, Theys J, Smaill JB, Patterson AV. Mowday AM, et al. Among authors: Dubois LJ. Cancers (Basel). 2016 Jun 28;8(7):63. doi: 10.3390/cancers8070063. Cancers (Basel). 2016. PMID: 27367731 Free PMC article. Review.
34 results
Jump to page
Feedback